Re: Moxifloxacin should not be discounted in the treatment of bacterial meningitis

J Infect. 2016 Aug;73(2):174-5. doi: 10.1016/j.jinf.2016.05.005. Epub 2016 Jun 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents
  • Fluoroquinolones*
  • Humans
  • Meningitis, Bacterial*
  • Moxifloxacin

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Moxifloxacin